Valeo Pharma Inc
F:VP2

Watchlist Manager
Valeo Pharma Inc Logo
Valeo Pharma Inc
F:VP2
Watchlist
Price: 0.005 EUR Market Closed
Market Cap: €832.5k

Wall St Price Targets

VP2 Price Targets Summary
Valeo Pharma Inc

There are no price targets for VP2.
Lowest Forecast
Price Target
Not Available
Average Forecast
Price Target
Not Available
Highest Forecast
Price Target
Not Available
Valeo Pharma Inc Competitors:
Price Targets
CPNREIT
CPN Retail Growth Leasehold REIT
0% Downside
OFN
Orell Fuessli AG
-23% Downside
PTGX
Protagonist Therapeutics Inc
13% Upside
UUU
3U Holding AG
63% Upside

Revenue
Forecast

87% / Year
Past Growth
14% / Year
Estimated Growth
Estimates Accuracy
-2%
Average Miss
87% / Year
Past Growth
14% / Year
Estimated Growth
Estimates Accuracy
-2%
Average Miss

Over the last 6 years, the compound annual growth rate for Revenue has been 87%. The projected CAGR for the next 2 years is 14%.

Operating Income
Forecast

N/A
Past Growth
N/A
Estimated Growth
Estimates Accuracy
19%
Average Beat
N/A
Past Growth
N/A
Estimated Growth
Estimates Accuracy
19%
Average Beat

Net Income
Forecast

N/A
Past Growth
N/A
Estimated Growth
Estimates Accuracy
-2%
Average Miss
N/A
Past Growth
N/A
Estimated Growth
Estimates Accuracy
-2%
Average Miss
Why do you have more estimates than other sites?

Our estimates are sourced from the pool of sell-side and buy-side analysts that we have access to. What you see on other sites is mostly sourced from sell-side analysts.

What is VP2's stock price target?
Not Available

VP2 does not have any price targets made by Wall Street professionals.

What is the Revenue forecast for Valeo Pharma Inc?
Projected CAGR
14%

Over the last 6 years, the compound annual growth rate for Revenue has been 87%. The projected CAGR for the next 2 years is 14%.

Back to Top
Get AI-powered insights for any company or topic.
Open AI Assistant

Intrinsic Value is all-important and is the only logical way to evaluate the relative attractiveness of investments and businesses.

Warren Buffett